Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Zanubrutinib
Obinutuzumab
Leukemia & Lymphoma Society
NCCN Guidelines for Patients
Cancer.gov
UpToDate